Published in Curr Treat Options Cardiovasc Med on September 25, 2017
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med (2017) 5.08
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med (2015) 4.18
Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. JAMA (2015) 4.00
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2015) 3.14
Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Imaging (2015) 2.34
The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst (2013) 2.20
A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals. JACC Cardiovasc Imaging (2015) 2.08
Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol (2011) 2.03
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 2.03
10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol (2015) 1.92
Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc (2013) 1.89
Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med (2006) 1.84
Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes (2014) 1.71
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2016) 1.53
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol (2016) 1.53
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med (2014) 1.47
Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT. N Engl J Med (2015) 1.41
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation (2013) 1.28
Non-cardiovascular effects associated with statins. BMJ (2014) 1.24
Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J (2013) 1.22
Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients. Circ Cardiovasc Imaging (2014) 1.08
Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. J Am Coll Cardiol (2015) 1.07
Cardiovascular lifetime risk predicts incidence of coronary calcification in individuals with low short-term risk: the Dallas Heart Study. J Am Heart Assoc (2014) 0.90
Risk and the physics of clinical prediction. Am J Cardiol (2014) 0.87
What to say and how to say it: effective communication for cardiovascular disease prevention. Curr Opin Cardiol (2016) 0.81
The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis (2014) 0.81
The new "intermediate risk" group: a comparative analysis of the new 2013 ACC/AHA risk assessment guidelines versus prior guidelines in men. Atherosclerosis (2014) 0.80
Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy. Circulation (2016) 0.80
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. J Am Coll Cardiol (2016) 0.78
Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA (2016) 0.77
Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death. JAMA Cardiol (2017) 0.77
Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population. Int J Cardiol (2015) 0.77
Coronary Artery Calcium and Shared Decision Making. JACC Cardiovasc Imaging (2016) 0.76
Personalizing Treatment: Between Primary and Secondary Prevention. Am J Cardiol (2016) 0.76
The Case For and Against a Coronary Artery Calcium Trial: Means, Motive, and Opportunity. JACC Cardiovasc Imaging (2016) 0.76
Coronary Artery Calcium: Need for More Clarity in Guidelines. JACC Cardiovasc Imaging (2016) 0.76
CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. JACC Cardiovasc Imaging (2016) 0.76
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines. Mayo Clin Proc (2015) 0.76
The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging (2017) 0.76
Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr (2017) 0.76
Potential for Net Benefit Should Guide Preventive Therapy. Circulation (2017) 0.76
Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. JACC Cardiovasc Imaging (2017) 0.76
Coronary Artery Calcium Scoring: Are We There Yet? J Am Coll Cardiol (2015) 0.75
Providing Evidence for Subclinical CVD in Risk Assessment. Glob Heart (2016) 0.75
Cholesterol guidelines do not endorse "one size fits all": the strategy begins with a discussion. J Am Coll Cardiol (2015) 0.75
Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction. J Am Coll Cardiol (2016) 0.75
Overhauling Cardiovascular Risk Prediction in Primary Prevention: Difficult Journey Worth the Destination. Circ Cardiovasc Qual Outcomes (2015) 0.75